Procter & Gamble Health Share Price
Start SIP in Procter & Gamble Health
Start SIPProcter & Gamble Health Performance
Day Range
- Low 5,166
- High 5,235
52 Week Range
- Low 4,637
- High 5,643
- Open Price5,235
- Previous Close5,205
- Volume2461
Procter & Gamble Health Investment Rating
-
Master Rating:
-
Procter & Gamble Health has an operating revenue of Rs. 1,151.26 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 24% is great, ROE of 37% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its key moving averages, around -0% and 3% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 20 which is a POOR score indicating inconsistency in earnings, a RS Rating of 25 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 59 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 284 | 252 | 310 | 305 | 301 | 321 |
| Operating Expenses Qtr Cr | 236 | 185 | 208 | 216 | 256 | 243 |
| Operating Profit Qtr Cr | 48 | 67 | 102 | 89 | 45 | 80 |
| Depreciation Qtr Cr | 7 | 7 | 7 | 6 | 6 | 6 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 6 | 16 | 28 | 22 | 14 | 19 |
| Net Profit Qtr Cr | 17 | 47 | 72 | 66 | 30 | 59 |
Procter & Gamble Health Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹5,253.86
- 50 Day
- ₹5,195.88
- 100 Day
- ₹5,119.87
- 200 Day
- ₹5,056.54
- 20 Day
- ₹5,263.85
- 50 Day
- ₹5,218.84
- 100 Day
- ₹5,042.71
- 200 Day
- ₹5,039.88
Procter & Gamble Health Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 5,302.55 |
| Second Resistance | 5,399.95 |
| Third Resistance | 5,458.15 |
| RSI | 47.44 |
| MFI | 77.24 |
| MACD Single Line | 21.66 |
| MACD | 21.28 |
| Support | |
|---|---|
| First Support | 5,146.95 |
| Second Support | 5,088.75 |
| Third Supoort | 4,991.35 |
Procter & Gamble Health Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 8,526 | 501,414 | 58.81 |
| Week | 19,706 | 1,410,753 | 71.59 |
| 1 Month | 12,625 | 722,504 | 57.23 |
| 6 Month | 12,948 | 903,887 | 69.81 |
Procter & Gamble Health Result Highlights
Procter & Gamble Health Synopsis
NSE-Medical-Generic Drugs
P&G Health is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1151.26 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2024. Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726.| Market Cap | 8,640 |
| Sales | 1,151 |
| Shares in Float | 0.80 |
| No of funds | 139 |
| Yield | 2.11 |
| Book Value | 16.05 |
| U/D Vol ratio | 1.6 |
| LTDebt / Equity | |
| Alpha | |
| Beta | 0.23 |
Procter & Gamble Health Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 51.82% | 51.82% | 51.82% | 51.82% |
| Mutual Funds | 10.19% | 9.86% | 8.98% | 8.41% |
| Insurance Companies | 4.05% | 3.55% | 3.41% | 3.71% |
| Foreign Portfolio Investors | 6.39% | 6.24% | 7.6% | 7.38% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 21.83% | 22.61% | 22.9% | 23.44% |
| Others | 5.72% | 5.92% | 5.29% | 5.24% |
Procter & Gamble Health Management
| Name | Designation |
|---|---|
| Mr. Suresh Talwar | Chairman & Ind.Director |
| Mr. Milind Thatte | Managing Director |
| Mr. Lokesh Chandak | Executive Director & CFO |
| Ms. Seema Sambasivan | Non Executive Director |
| Mr. Aalok Agrawal | Non Executive Director |
| Mrs. Rani Jadhav | Independent Director |
| Mr. S Madhavan | Independent Director |
Procter & Gamble Health Forecast
Price Estimates
Procter & Gamble Health Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-21 | Audited Results & Final Dividend | |
| 2024-05-02 | Quarterly Results | |
| 2024-02-06 | Quarterly Results & Interim Dividend | |
| 2023-11-03 | Quarterly Results | |
| 2023-08-23 | Audited Results & Final Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-02-14 | INTERIM | Rs.50.00 per share(500%)Interim Dividend |
| 2024-02-14 | SPECIAL | Rs.150.00 per share(1500%)Special Dividend |
| 2023-02-13 | INTERIM | Rs.45.00 per share(450%)Interim Dividend |
| 2022-05-13 | INTERIM | Rs.41.00 per share(410%)Interim Dividend |
Procter & Gamble Health FAQs
What is Share Price of Procter & Gamble Health ?
Procter & Gamble Health share price is ₹5,172 As on 16 September, 2024 | 12:14
What is the Market Cap of Procter & Gamble Health ?
The Market Cap of Procter & Gamble Health is ₹8585.3 Cr As on 16 September, 2024 | 12:14
What is the P/E ratio of Procter & Gamble Health ?
The P/E ratio of Procter & Gamble Health is 42.7 As on 16 September, 2024 | 12:14
What is the PB ratio of Procter & Gamble Health ?
The PB ratio of Procter & Gamble Health is 16 As on 16 September, 2024 | 12:14